These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8462772)

  • 1. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.
    Rich SS; French LR; Sprafka JM; Clements JP; Goetz FC
    Diabetologia; 1993 Mar; 36(3):234-8. PubMed ID: 8462772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin.
    Rich SS; Panter SS; Goetz FC; Hedlund B; Barbosa J
    Diabetologia; 1991 May; 34(5):350-5. PubMed ID: 1864490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance.
    MacDonald MJ; Gottschall J; Hunter JB; Winter KL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7049-53. PubMed ID: 3489237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess of maternal HLA-DR3 antigens in HLA DR3,4 positive type 1 (insulin-dependent) diabetic patients.
    Deschamps I; Hors J; Clerget-Darpoux F; Gardais E; Robert JJ; Marcelli-Berge A; Lestradet H; Dausset J
    Diabetologia; 1990 Jul; 33(7):425-30. PubMed ID: 2401398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes.
    Bain SC; Rowe BR; Barnett AH; Todd JA
    Diabetes; 1994 Dec; 43(12):1462-8. PubMed ID: 7958500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential transmission of diabetic alleles within the HLA gene complex.
    Vadheim CM; Rotter JI; Maclaren NK; Riley WJ; Anderson CE
    N Engl J Med; 1986 Nov; 315(21):1314-8. PubMed ID: 3490623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.
    Undlien DE; Friede T; Rammensee HG; Joner G; Dahl-Jørgensen K; Søvik O; Akselsen HE; Knutsen I; Rønningen KS; Thorsby E
    Diabetes; 1997 Jan; 46(1):143-9. PubMed ID: 8971095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions.
    Hummel M; Marienfeld S; Huppmann M; Knopff A; Voigt M; Bonifacio E; Ziegler AG
    Diabetologia; 2007 Apr; 50(4):850-8. PubMed ID: 17310371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.
    Wolf E; Spencer KM; Cudworth AG
    Diabetologia; 1983 Apr; 24(4):224-30. PubMed ID: 6407886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients.
    Tait BD; Mraz G; Harrison LC
    Diabetes; 1988 Jul; 37(7):926-9. PubMed ID: 3260201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA DR4-DQw3.1 and 3.2 haplotypes among insulin-dependent diabetics and their unaffected sibs in the GAW5 data.
    Gogolin KJ; Spielman RS
    Genet Epidemiol; 1989; 6(1):113-6. PubMed ID: 2567253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease.
    Awdeh ZL; Yunis EJ; Audeh MJ; Fici D; Pugliese A; Larsen CE; Alper CA
    J Autoimmun; 2006 Nov; 27(3):174-81. PubMed ID: 17052889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.
    Itoh A; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Irie J; Nakagawa Y; Shigihara T; Kanazawa Y; Okubo Y; Motohashi Y; Maruyama T; Saruta T
    Ann N Y Acad Sci; 2004 Dec; 1037():33-40. PubMed ID: 15699491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.
    Aribi M; Moulessehoul S; Benabadji AB; Kendoucitani M
    BMC Genet; 2004 Aug; 5():24. PubMed ID: 15331022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA type and the genetic risk for type 1 diabetes mellitus.
    MacMillan DR; Foster MB; Key MP
    J Ky Med Assoc; 1991 Jan; 89(1):19-21. PubMed ID: 1995752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.